FrailSafe

Sensing and predictive treatment of frailty and associated co-morbidities using advanced personalized patient models and advanced interventions
Project ID
Funding Organization:
Funding Programme:
Horizon 2020 – Personalizing Health and Care
Funding Instrument:
Research & Innovation Action
Start Date:
01/01/2016
Duration:
36 months
Total Budget:
3,820,896 EUR
ITI Budget:
447,000 EUR
Scientific Responsible:

Ageing population is steeply increasing worldwide. A consequence of age related decline is the clinical condition of frailty. Frailty is a biological syndrome of decreased reserve and resistance to stressors, resulting from cumulative declines across multiple physiologic systems and causing vulnerability to adverse outcomes. Susceptibility to stressors is influenced by biological, behavioral, environmental, and social risk factors, with the main consequence being an increased risk for multiple adverse health outcomes, including disability, morbidity, falls, hospitalization, institutionalization, and death. However, frailty is a dynamic and not an irreversible process; it seems preventable, may be delayed, or reversed. Our understanding of frailty has markedly improved over the last five years, yet there are many issues yet to be resolved.FrailSafe aims to better understand frailty and its relation to co-morbidities; to identify quantitative and qualitative measures of frailty through advanced data mining approaches on multiparametric data and use them to predict short and long-term outcome and risk of frailty; to develop real life sensing (physical, cognitive, psychological, social) and intervention (guidelines, real-time feedback, AR serious games) platform offering physiological reserve and external challenges; to provide a digital patient model of frailty sensitive to several dynamic parameters, including physiological, behavioural and contextual; this model being the key for developing and testing pharmaceutical and non-pharmaceutical interventions; to create “prevent-frailty” evidence-based recommendations for the elderly; to strengthen the motor, cognitive, and other “anti-frailty” activities through the delivery of personalized treatment programmes, monitoring alerts, guidance and education; and to achieve all with a safe, unobtrusive and acceptable system for the ageing population while reducing the cost of health care systems.

Consortium

UNIVERSITY OF PATRAS – Greece
BRAINSTORM MULTIMEDIA S.L. – Spain
SMARTEX S.R.L. – Italy
AGE PLATFORM EUROPE AISBL – Belgium
CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS (CERTH) – Greece
AGECARE (CYPRUS) LTD (MATERIA GROUP) – Cyprus
GRUPPO SIGLA SRL – Italy
HYPERTECH ANONYMOS VIOMICHANIKI EMPORIKI ETAIREIA PLIROFORIKIS KAI NEON TECHNOLOGION (HYPERTECH AE) – Greece
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) – France

Contact

Dr. Dimitrios Tzovaras
(Scientific Responsible)
Building A - Office 1.1Α

Information Technologies Institute
Centre of Research & Technology - Hellas
6th km Harilaou - Thermis, 57001, Thermi - Thessaloniki
Tel.: +30 2311 257777
Fax: +30 2310 474128
Email: Dimitrios.Tzovaras@iti.gr

Skip to content